Verrica Pharmaceuticals (Nasdaq: VRCA) reports positive results for its pivotal Phase 3 CAMP-1 and CAMP-2 trials of
What is the ARCHES Trial? Sponsored by Astellas Pharma and Medivation (Pfizer), it is a study is to evaluate the
MD Magazine’s Kevin Kunzmann reports on Joseph Han, MD and the SINUS-24 Trial results. Han revealed monoclonal ...
Lupus News Today reported on a Phase 1 trial involving BIIB059, an antibody that targets a receptor of plasmacytoid
A prostate cancer treatment shows considerable promise according to a full set of results from a recent ARAMIS ...
No results found.